Molecular Biology

In the Group for Molecular Biology we study molecular mechanisms that underlie cardiovascular, pulmonary and malignant We primarily aim to elucidate basic physiological processes and etiopathological mechanisms in these diseases, with focus on translational potential of our research. Our main interests include:
- Molecular mechanisms of various biological processes including haemostasis, inflammation, tissue remodeling and response to oxidative stress.
- Influence of gene variants and environmental factors on the phenotype.
- Identification and functional characterization of molecular markers.
- In vitro(primary and continuous cell lines) and in vivo(zebra fish) study of selected physiological and pathological interests.
Group for Molecular Biology successfully collaborates with a number of scientific research and health institutions in Serbia, as well as eminent foreign institutes. We are open to all types of cooperation.
- IMGGE work program for 2023
  Ministry of Education, Science and Technological Development of the Republic of Serbia, 451-03-47/2023-01/ 200042
  Principal Investigator: Dr Ivana Strahinic, IMGGE
  Participants: all IMGGE researchers
- GENIUS - GENETIC AND ENVIRONMENTAL INFLUENCES ON PSYCHOLOGICAL ADAPTATION OF CHILDREN AND ADULTS
  Science Fund of the Republic of Serbia, Program IDEAS, 7744418, 2021-2024
  Principal Investigator: Dr Snezana Smederevac, Faculty of Philosophy, University of Novi Sad
  Participant: Dr Jelena Kusic Tisma
- ExplOMV - Exploring Bacterial OMV (Outer Membrane Vesicles)-sRNAs Mediated Interkingdom Communication with Plants and Fungi
  Science Fund of the Republic of Serbia, Program IDEAS, 7744906, 2021-2024
  Principal Investigator: Dr Dragana Nikolic, IMGGE
  Participant from IMGGE: Dr Aleksandra Divac Rankov
- Pro-Belgrade - Could Prothrombin Belgrade mutation affect blood vessels? A new insight into thrombosis mechanism
  Science Fund of the Republic of Serbia, Serbian Science and Diaspora Collaboration Program: Knowledge Exchange Vouchers, 6476784, 2020-2023
  Principal Investigator: Dr Valentina Djordjevic, IMGGE
  Participant from IMGGE: Sofija Dunjic Manevski
- ProORC - Profiling ORC genetics and regulation in cance
  Science Fund of the Republic of Serbia, Serbian Science and Diaspora Collaboration Program: Knowledge Exchange Vouchers, 6504965, 2020-2023
  Principal Investigator: Dr Jelena Kusic Tisma, IMGGE
- GREENTECH-Active substances from supercritical plant extracts for high value added products
  Eureka! network program and Ministry of Education, Science and Technological Development of the Republic of Serbia, 13632, 2022-2024
  Principal Investigator: Prof. dr Vanja Tadic, Institute for Medicinal Plants Research "Dr. Josif Pancic"
  Participant: Dr Dusan Usjak
- SCIENCE ON THE MOVE - FROM LAB TO STREETS & SCHOOL (SCIENCESCOOL)
  European Comission, 101061631, 2022-2023
  Principal Investigator: Dr Biljana Sljukic Paunkovic, Faculty of Physical Chemistry, University of Belgrade
  Participant from IMGGE: Dr Aleksandra Divac Rankov
HEAD OF THE GROUP
- Valentina Đorđević - Full research professor
ASSOCIATE RESEARCH PROFESSOR
ASSISTANT RESEARCH PROFESSOR
- Maja Gvozdenov
- Dušan Ušjak
RESEARCH ASSISTANT
- Sofija Dunjić Manevski
- Marija Cumbo
JUNIOR RESEARCHER
- Martina Mia Mitić
- Hristina Mitrović
OTHERS
- Sara Trifunović, Researcher
- Alpha-1 antitrypsin expression is upregulated in multidrug-resistant cancer cells
  Divac Rankov A, Jovanović Stojanov S, Dragoj M, Ljujić M
  Histochem Cell Biol 2022. doi: 10.1007/s00418-022-02172-3
- Lactobacillus brevis BGZLS10-17 and Lb. plantarum BGPKM22 exhibit anti-inflammatory effect by attenuation of NF-κB and MAPK signaling in human bronchial epithelial cells
  Stankovic M, Veljovic K, Popovic N, Kojic S, Dunjic Manevski S, Radojkovic D, Golic N
  Int J Mol Sci 2022;23(10):5547
- Thrombosis risk assessment in patients with congenital thrombophilia during COVID - 19 infection
  Kovac M, Mitic G, Milenkovic M, Basaric D, Tomic B, Markovic O, Zdravkovic M, Ignjatovic V
  Thromb Res 2022;218:151-156
- Electronic cigarette liquids impair metabolic cooperation and alter proteomic profiles in V79 cells
  Trifunovic S, Smiljanić K, Sickmann A, Solari FA, Kolarevic S, Divac Rankov A, Ljujic M
  Respir Res 2022;23(1):191
- Molecular Diagnostics of Cystic Fibrosis in Serbia: Our Approach to Meet the Diagnostic Challenges
  Divac Rankov A, Kusic-Tisma J, Ljujic M, Nikolic A, Milosevic K, Vilotijevic Dautovic G, Radojkovic D
  Genet Test Mol Biomarkers 2020;24(4):212-216
- The silence speaks, but we do not listen: synonymous c.1824C>T gene variant in the last exon of the prothrombin gene as a new prothrombotic risk factor
  Pruner I, Farm M, Tomic B, Gvozdenov M, Kovac M, Miljic P, Soutari NMH, Antovic A, Radojkovic D, Antovic J, Djordjevic V
  Clin Chem 2020;66(2):379-389
- Pharmacogenetics of clopidogrel therapy and neurointerventional procedures: we need precision data for precision medicine
  Rakicevic L, Nestorovic A
  Clin Pharmacol Ther 2019;105(3):547-549
- Analysis of the CYP2C19 genotype associated with bleeding in Serbian STEMI patients who have undergone primary PCI and treatment with clopidogrel.
  Novkovic M, Matic D, Kusic-Tisma J, Antonijevic N, Radojkovic D, Rakicevic L
  Eur J Clin Pharmacol 2018;74(4):443-451
- Targeting autophagy to modulate cell survival: a comparative analysis in cancer, normal and embryonic cells.
  Divac Rankov A, Ljujić M, Petrić M, Radojković D, Pešić M, Dinić J
  Histochem Cell Biol 2017;148(5):529-544
- Clinical and biochemical characterization of the Prothrombin Belgrade mutation in a large Serbian pedigree: new insights into antithrombin resistance mechanism
  Miljic P, Gvozdenov M, Takagi Y, Takagi A, Pruner I, Dragojevic M, Tomic B, Bodrozic J, Kojima T, Radojkovic D, Djordjevic V
  J Thromb Haemost 2017;15(4):670-677
Vojvode Stepe 444a
P.O BOX 23
11010 Beograd, Srbija

Tel: +381 11 3976658
Mob:+381 65 3976658
Faks: +381 11 3975808

labmolbio@imgge.bg.ac.rs